Genecopoeia provides OncoSpot™ NGS Spike-in Reference Standards for monitoring the whole process of the detection. The CRISPR method is employed to modify the genome of tumour cells, introducing single nucleotide mutations or in-frame indel mutations. Concurrently, spike-in markers are set up using our patented technology ‘DNA reference standard and use thereof’.
Products
AccelerRT® 5G Full Length cDNA Synthesis & Amplification Kit
[tab:Product Information] The AccelerRT® 5G Full Length cDNA Synthesis & Amplification Kit can synthesize cDNA ranging from 1-1000 cells or 10...
DNase I
[tab:Product Information] DNase I is an endonuclease that digests single- and double- stranded DNA. It hydrolyzes phosphodiester...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.